Less Ads, More Data, More Tools Register for FREE

Pin to quick picksXaar Regulatory News (XAR)

Share Price Information for Xaar (XAR)

Share Price is delayed by 15 minutes
Get Live Data
145.00    3.00 (2.11%)
Bid:
140.50
Ask:
144.50
Spread: 4.00 (2.847%)
Market Cap: £113.79m
XAR Live PriceLast checked at - London Stock Exchange

Intraday Xaar Share Chart

Interim Management Statement

2 Oct 2014 07:00

RNS Number : 2305T
Xaar PLC
02 October 2014
 



2 October 2014

 

Xaar plc

 

Interim Management Statement

Xaar plc ("Xaar", "the Group" or "the Company"), the digital inkjet printing technology Group headquartered in Cambridge, UK, is providing an Interim Management Statement covering trading from 1 July 2014.

 

As stated in the Interim Results announcement on 28 August 2014, demand for Xaar's products from the ceramic tile market softened during the third quarter of the year as a result of a slowdown in construction activity in China. The Company's exposure to China is significant, as almost half of the world's ceramic tile output is reported as manufactured and consumed in China. Revenue into the global ceramic tile market represented around two thirds of the Group's sales in 2013.

Monitoring of the ceramic tile market in China has indicated a further decline in activity resulting in excess manufacturing capacity being idled. As a consequence, forecast orders from Xaar's OEMs in this market for the remainder of the year have further reduced, such that the Board now expects total revenue for 2014 to be 5%-10% below the bottom of the previously announced range of £115-125 million.

Although visibility into 2015 remains low, based on all of the information currently available to the Group concerning the ceramic tile market in China, the Group is now planning to take action to reduce costs in anticipation of total Group revenue for 2015 being below £100 million.

Action will be taken immediately to reduce costs in line with the reduced expectation for sales in 2015. This is expected to result in a 15% reduction in operating expenditures, and potentially a total reduction in headcount (subject to consultation) of approximately 20% of the current global workforce of around 800 employees.

The cost reductions aim to achieve a reasonable level of financial operating performance in 2015, whilst ensuring that Xaar can fulfil its key strategic objectives.

Ian Dinwoodie, Chief Executive, commented, "We are highly disappointed to have to make this level of cost reduction given the progress achieved over the last four years. Our exposure to the ceramic tile market in China, which delivered such strong growth over the last few years, is now driving a reduction in our sales. This change re-emphasises the need for Xaar's revenues over time to become more broadly spread across multiple markets and applications. Our competitive position remains strong through our established market leading products, recently announced offerings, and planned future launches. Development efforts on both our Bulk technology and our Thin Film technology provide an excellent basis for our future success as the digitalisation of industrial and commercial printing continues".

A conference call for analysts will take place at 8.00am this morning. The conference call can be accessed by dialling +44 (0)203 139 4830 and using pin code 80375705#.

 

Contacts 

Xaar plc

Ian Dinwoodie, Chief Executive Officer

01223-423663

Alex Bevis, Finance Director

www.xaar.com

Tulchan Communications

Tom Buchanan

Christian Cowley

Victoria Huxster

 

020-7353-4200

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSBRBDGXSGBGSB
Date   Source Headline
3rd Oct 20164:33 pmRNSTotal Voting Rights
29th Sep 20169:25 amRNSBoard Changes
1st Sep 201610:44 amRNSTotal Voting Rights
26th Aug 201611:44 amRNSGrant of Options
24th Aug 20167:00 amRNS2016 Interim Results
1st Aug 20162:07 pmRNSTotal Voting Rights
13th Jul 20167:00 amRNSScheduled Trading Statement
12th Jul 20166:02 pmRNSHolding(s) in Company
1st Jul 201610:56 amRNSBlock listing Interim Review
1st Jul 201610:53 amRNSTotal Voting Rights
1st Jul 20169:32 amRNSNotice of Scheduled Trading Statement
1st Jul 20167:00 amRNSXAAR AQUIRES ENGINEERED PRINTING SOLUTIONS
2nd Jun 20163:00 pmRNSLAUNCH OF PRINTHEAD FAMILY & STRATEGIC PARTNERSHIP
1st Jun 20163:39 pmRNSTotal Voting Rights
19th May 20163:01 pmRNSResult of AGM - Replacement
18th May 20163:03 pmRNSResult of AGM
13th May 201610:09 amRNSGrant of Options
9th May 201612:42 pmRNSDirector Shareholding
4th May 20167:00 amRNSAppointment of Non-Executive Director
29th Apr 20169:00 amRNSTotal Voting Rights
15th Apr 20169:59 amRNSDirector/PDMR Shareholding - SIP Purchase
5th Apr 20163:17 pmRNSHolding(s) in Company
4th Apr 20161:58 pmRNSGrant of Options
1st Apr 20161:50 pmRNSHolding(s) in Company
1st Apr 20169:03 amRNSTotal Voting Rights
22nd Mar 201612:04 pmRNSXAAR LAUNCHES NEW FAMILY OF PRINTHEADS
18th Mar 201612:07 pmRNSDirector/PDMR Shareholding
16th Mar 20167:00 amRNS2015 Full Year Results, 2020 Vision
7th Mar 201610:00 amRNSHolding(s) in Company
1st Mar 201610:13 amRNSTotal Voting Rights
1st Feb 20162:41 pmRNSTotal Voting Rights
22nd Jan 201612:02 pmRNSHolding(s) in Company
18th Jan 20166:16 pmRNSHolding(s) in Company
13th Jan 20167:00 amRNSScheduled Trading Statement
6th Jan 20167:00 amRNSXAAR STRENGTHENS ITS 3D PRINTING BUSINESS
4th Jan 20164:12 pmRNSBlocklisting Interim Review
4th Jan 20163:27 pmRNSTotal Voting Rights
17th Dec 201510:07 amRNSDirector Shareholding
11th Dec 20157:00 amRNSBoard Changes
9th Dec 20154:56 pmRNSHolding(s) in Company
1st Dec 20155:52 pmRNSTotal Voting Rights
25th Nov 20153:46 pmRNSHolding(s) in Company
16th Nov 20159:50 amRNSHolding(s) in Company
9th Nov 20151:53 pmRNSDirector/PDMR Shareholding
4th Nov 20157:00 amRNSInterim Management Statement
2nd Nov 20152:43 pmRNSTotal Voting Rights
7th Oct 20157:00 amRNSNotice of Trading Statement
1st Oct 201510:42 amRNSTotal Voting Rights
1st Sep 20152:43 pmRNSTotal Voting Rights
28th Aug 20153:44 pmRNSDirector Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.